2024's Pivotal Pharma Innovations and Challenges
Originally Published 1 year ago — by Gizmodo
In 2024, significant medical breakthroughs have emerged, including the approval of Orlynvah, a novel antibiotic for resistant UTIs, and Cobenfy, a new schizophrenia drug targeting acetylcholine. A promising twice-yearly HIV prevention injection, lenacapavir, has shown over 99% effectiveness in trials. Additionally, the first treatments for Niemann-Pick disease type C have been approved, and Bayer's elinzanetant shows promise for treating hot flashes. These advancements highlight ongoing progress in combating antibiotic resistance, improving mental health treatments, and enhancing disease prevention.